The CF Wind Sprint video series offers quick tips for living with CF. Topics include traveling, nutrition,exercise and treatments.
Every day, researchers around the world come one step closer to discovering a cure for cystic fibrosis. In the meantime, the CF drug “pipeline” ensures therapies are moving from the laboratory to the marketplace. We keep an eye on medical news sources from around the world and report on these developments as they occur.

Abbott Test Assists in CF Screening


A diagnostic test from Abbott provides information used for CF carrier screening, newborn screening and confirmation of CF diagnoses in newborns and children.

The Cystic Fibrosis Genotyping Assay looks for and examines mutations and variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene in human DNA. The panel includes mutations and variants recommended by the American College of Medical Genetics and the American College of Obstetricians and Gynecologists, plus additional mutiethnic mutations.

According to Abbott, the Cystic Fibrosis Genotyping Assay provides information intended to be used for carrier screening in adults of reproductive age, as an aid in newborn screening, and in confirmatory diagnostic testing in newborns and children. The test is not indicated for use in fetal diagnostic or pre-implantation testing. This test is also not indicated for stand-alone diagnostic purposes.

For more information, please visit the Abbott Molecular website.

Source: Abbott